{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["ca488e71-6e8f-4fc3-8a03-e6c1ce56e623", "Q2", 20744, "TIBER CREEK GROUP", 127202, "BAY BRIDGE STRATEGIES, INC. (ON BEHALF OF BIOCRYST PHARMACEUTICALS)", 2014, "second_quarter", "2014-07-21T15:34:23.523000-04:00", 20000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/ca488e71-6e8f-4fc3-8a03-e6c1ce56e623/\", \"filing_uuid\": \"ca488e71-6e8f-4fc3-8a03-e6c1ce56e623\", \"filing_type\": \"Q2\", \"filing_type_display\": \"2nd Quarter - Report\", \"filing_year\": 2014, \"filing_period\": \"second_quarter\", \"filing_period_display\": \"2nd Quarter (Apr 1 - June 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/ca488e71-6e8f-4fc3-8a03-e6c1ce56e623/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"20000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Jeffrey J. Peck, Partner\", \"dt_posted\": \"2014-07-21T15:34:23.523000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"1300 CONNECTICUT AVENUE, NW\", \"registrant_address_2\": \"SIXTH FLOOR\", \"registrant_different_address\": false, \"registrant_city\": \"WASHINGTON\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20036\", \"registrant\": {\"id\": 20744, \"url\": \"https://lda.senate.gov/api/v1/registrants/20744/\", \"house_registrant_id\": 31587, \"name\": \"TIBER CREEK GROUP\", \"description\": \"Government Relations.\", \"address_1\": \"750 9th Street NW\", \"address_2\": \"Suite 501\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20001\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"GRACE BAUM\", \"contact_telephone\": \"+1 202-381-6896\", \"dt_updated\": \"2026-01-28T11:50:36.069441-05:00\"}, \"client\": {\"id\": 127202, \"url\": \"https://lda.senate.gov/api/v1/clients/127202/\", \"client_id\": 1005510, \"name\": \"BAY BRIDGE STRATEGIES, INC. (ON BEHALF OF BIOCRYST PHARMACEUTICALS)\", \"general_description\": \"Pharmaceutical company.\", \"client_government_entity\": false, \"client_self_select\": null, \"state\": \"NC\", \"state_display\": \"North Carolina\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"NC\", \"ppb_state_display\": \"North Carolina\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2014-03-01\"}, \"lobbying_activities\": [{\"general_issue_code\": \"DIS\", \"general_issue_code_display\": \"Disaster Planning/Emergencies\", \"description\": \"Issues related to pandemic preparedness and biodefense.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 53494, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ANDREW\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"MCKECHNIE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 6542, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"SEAN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"RICHARDSON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 52662, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"LINDSEY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"LEDWIN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MED\", \"general_issue_code_display\": \"Medical/Disease Research/Clinical Labs\", \"description\": \"Issues related to pandemic preparedness and biodefense.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 53494, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ANDREW\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"MCKECHNIE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 6542, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"SEAN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"RICHARDSON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 52662, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"LINDSEY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"LEDWIN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["ca488e71-6e8f-4fc3-8a03-e6c1ce56e623"], "units": {}, "query_ms": 14.278072048909962, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}